Rotigaptide
Alternative Names: GAP-486; WAY 214486; ZP 123Latest Information Update: 05 Nov 2023
At a glance
- Originator Zealand Pharma
- Class Antiarrhythmics
- Mechanism of Action Gap junction modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Atrial fibrillation; Ventricular arrhythmias
Most Recent Events
- 21 Dec 2005 Data presented at the 78th Scientific Sessions of the American Heart Association (AHA-2005) have been added to the pharmacokinetics and Arrhythmias pharmacodynamics sections
- 09 Nov 2005 Phase-I clinical trials in Ventricular arrhythmias in Denmark (unspecified route)
- 01 Jun 2005 Phase-II clinical trials in Ventricular arrhythmias in USA (unspecified route)